News

MedPage Today on MSN21h
Novel Anti-Amyloid Drug Aims to Outperform Current Standards
TORONTO -- An investigational antibody drug, designed to cross the blood-brain barrier (BBB) to eliminate amyloid-beta ...
AZoSensors on MSN7h
Early Detection of Alzheimer's Disease with Novel Graphene Foam Sensor
This graphene foam biosensor offers high sensitivity for tau protein detection, enabling early Alzheimer's diagnosis and ...
DelveInsight Business Research, LLP: Alpha-synuclein Inhibitors Market to Witness Strong CAGR Through 2034, Driven by Advances in Neurodegenerative Therapies | DelveInsight
No alpha-synuclein inhibitors are approved, underscoring a major need for therapies that slow or halt Parkinson's progression. Developing safe, brain-penetrant drugs that target toxic alpha-synuclein ...